RANZCP homepage
Clinical guidelines & publications library
Showing 1-2
of 2
-
Application to the PBAC July 2024 Agenda for the Subsidy of Lecanemab and Esketamine
Ketamine
RANZCP Submission to the Pharmaceutical Benefits Advisory Committee (PBAC) regarding the Application to the PBAC July 2024 Agenda for the Subsidy of Lecanemab and Esketamine
Submission- Last updated: Jun 2024
- Published in Australia
- 07AUS
-
Use of ketamine in psychiatric practice
Ethics, Ketamine, Professionalism
Information for psychiatrists about the potential utility of ketamine in psychiatric practice. PDF Clinical guideline
Clinical guideline- Last updated: Jul 2022
- Published in Australia
